Publication & Citation Trends
Publications
153 total
Abstract 582: Selection of a novel toll-like receptor 7 (TLR7) agonist PRX034 for immunotherapy of cancer
Cited by 1
Semantic Scholar
Abstract 3262: Discovery of a series of novel toll-like receptor 7 agonists for systemic immunotherapy of cancer
Cited by 0
Semantic Scholar
a phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
Cited by 0
Semantic Scholar
Discovery of a novel Toll-like Receptor 7 agonist for systemic immunotherapy of cancer.
Cited by 0
Semantic Scholar
Narrow Spectrum Kinase Inhibitors Demonstrate Promise for the Treatment of Dry Eye Disease and Other Ocular Inflammatory Disorders. OA
Cited by 14
Semantic Scholar
P359 A novel phase 1 trial design to evaluate safety, tolerability, pharmacokinetics, and pharmacodynamics of TOP1288, a narrow spectrum kinase inhibitor, delivered topically to the colon via oral administration OA
Cited by 1
Semantic Scholar
Sa1775 - A Novel Phase 1 Trial Design to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Top1288, a Narrow Spectrum Kinase Inhibitor, Delivered Topically to the Colon via Oral Administration
Cited by 2
Semantic Scholar
P062 The narrow spectrum kinase inhibitor TOP1288 demonstrates potent anti-inflammatory effects in a T cell adoptive transfer colitis model through a topical mode of action. OA
Cited by 0
Semantic Scholar
Research Topics
Advanced Polymer Synthesis and Characterization
(21)
Surfactants and Colloidal Systems
(21)
Photochemistry and Electron Transfer Studies
(16)
Hepatitis C virus research
(12)
Analytical Chemistry and Sensors
(12)
Affiliations
Shinshu University
Pfizer (United States)
GlaxoSmithKline (United Kingdom)
Pfizer (United Kingdom)
Barking and Dagenham College